MARKET

SWTX

Springworks Therapeutics, Inc.
SWTX
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-13.4951
18.25
8.44
3,539,413,485.04
Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal
Reuters · 11/20/2025 11:30
Merck KGaA third-quarter net sales rise 1.0% to €5.3 billion
Reuters · 11/13/2025 06:01
Edgewise Therapeutics Appoints Michael Nofi as Chief Financial Officer
Reuters · 11/10/2025 13:02
European Commission Grants Approval for Merck KGaA's OGSIVEO as First-Ever Treatment for Desmoid Tumors in the EU
Reuters · 08/18/2025 13:05
Legendary Investor Stanley Druckenmiller Made Huge AI And Chipmaker Bets In Q2 — Here's What He Knows That You Don't
Benzinga · 08/18/2025 08:15
MEDIA-Merck KGaA plans $4 billion bond sale to fund SpringWorks Therapeutics acquisition - Bloomberg News
Reuters · 08/11/2025 21:00
SpringWorks Therapeutics Receives EC Conditional Marketing Approval For EZMEKLY In Treating NF1-PN Across Pediatric And Adult Patients
Benzinga · 07/18/2025 16:14
California Rep. Gilbert Ray Cisneros Sold Over $28K Worth of SpringWorks Therapeutics Inc Ordinary Shares Stock: Here's What You Should Know
Benzinga · 07/11/2025 15:00
More

Webull offers Springworks Therapeutics, Inc. stock information, including NASDAQ: SWTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SWTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SWTX stock methods without spending real money on the virtual paper trading platform.